Quick Answer
Twist Bioscience Corp reported Operating Income of -$136.26 million for fiscal year 2025.
Twist Bioscience Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$136.26M | +38.3% |
| 2024 | -$220.83M | -1.7% |
| 2023 | -$217.16M | +7.5% |
| 2022 | -$234.78M | -53.7% |
| 2021 | -$152.73M | -9.0% |
| 2020 | -$140.08M | -28.7% |
| 2019 | -$108.85M | -54.3% |
| 2018 | -$70.56M | -20.7% |
| 2017 | -$58.48M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$32.90M | +5.0% | -9.2% |
| June 30, 2025 | -$30.12M | +66.1% | +27.5% |
| March 31, 2025 | -$41.56M | +15.0% | -20.0% |
| December 31, 2024 | -$34.64M | +26.3% | +61.0% |
| June 30, 2024 | -$88.92M | -46.3% | -81.9% |
| March 31, 2024 | -$48.89M | +20.7% | -4.1% |
| December 31, 2023 | -$46.98M | -5.3% | +22.7% |
| June 30, 2023 | -$60.78M | +0.6% | +1.4% |
- Twist Bioscience Corp showed an increase of +38.3% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Twist Bioscience Corp’s operating income has declined by 133.0% (from -$58.48 million to -$136.26 million).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: